SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011393
Filing Date
2022-06-09
Accepted
2022-06-09 16:07:03
Documents
12
Period of Report
2022-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K reta-20220608.htm   iXBRL 8-K 81187
  Complete submission text file 0000950170-22-011393.txt   197529

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reta-20220608_pre.xml EX-101.PRE 10502
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reta-20220608_lab.xml EX-101.LAB 13186
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reta-20220608.xsd EX-101.SCH 2461
6 EXTRACTED XBRL INSTANCE DOCUMENT reta-20220608_htm.xml XML 4530
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 221006018
SIC: 2834 Pharmaceutical Preparations